Kevin J. Yeaman - 24 Nov 2025 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Issuer symbol
DLB
Transactions as of
24 Nov 2025
Net transactions value
-$562,150
Form type
4
Filing time
26 Nov 2025, 20:37:25 UTC
Previous filing
16 Oct 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
YEAMAN KEVIN J President and CEO, Director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO /s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 26 Nov 2025 0001200469

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Options Exercise $1,137,500 +25,000 +22% $45.50 139,725 24 Nov 2025 By a trust F1
transaction DLB Class A Common Stock Options Exercise $755,755 +11,699 +8.4% $64.60 151,424 24 Nov 2025 By a trust F1
transaction DLB Class A Common Stock Sale $2,455,405 -36,699 -24% $66.91 114,725 24 Nov 2025 By a trust F1, F2
transaction DLB Class A Common Stock Gift $0 -16,348 -14% $0.000000 98,377 26 Nov 2025 By a trust F1, F3
holding DLB Class A Common Stock 127,735 24 Nov 2025 Direct F4
holding DLB Class A Common Stock 3 24 Nov 2025 By a son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -25,000 -70% $0.000000 10,615 24 Nov 2025 Class A Common Stock 25,000 $45.50 By a trust F1, F5
transaction DLB Employee Stock Option (Right to Buy) Options Exercise $0 -11,699 -33% $0.000000 23,752 24 Nov 2025 Class A Common Stock 11,699 $64.60 By a trust F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
F2 The shares were sold in multiple transactions at prices ranging from $66.53 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025.
F3 On November 26, 2025, Mr. Yeaman gifted 16,348 shares of Class A Common Stock to a Donor-Advised Fund for the purpose of making charitable donations.
F4 Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F5 This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
F6 This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares.